|
KPTI Karyopharm Therapeutics Inc 1503802 |
| Balance Sheet |
|
Current Assets
|
156,492,000 |
|
Assets
|
164,418,000 |
|
Current Liabilities
|
92,264,000 |
|
Liabilities
|
350,435,000 |
|
Equity
|
-186,017,000 |
|
Shares Out
|
22,543,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-127,486,000 |
|
Investing Cash Flow
|
95,473,000 |
| Market Analysis |
Market Cap
|
215,288,614 |
|
Price
|
9.55 |
|
BVPS
|
43.20 |
|
PB
|
0.14 |
|
EPS
|
-17.93 |
|
PS
|
0.17 |
|
FCF
|
-32,013,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KPTI documents filed with the SEC.
KPTI Filings
Clear
